HEADER CELL CYCLE 20-DEC-22 8C1M TITLE AURORA A KINASE IN COMPLEX WITH TPX2-INHIBITOR 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AURORA KINASE A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AURORA 2,AURORA/IPL1-RELATED KINASE 1,ARK-1,AURORA-RELATED COMPND 5 KINASE 1,BREAST TUMOR-AMPLIFIED KINASE,IPL1- AND AURORA-RELATED COMPND 6 KINASE 1,SERINE/THREONINE-PROTEIN KINASE 15,SERINE/THREONINE-PROTEIN COMPND 7 KINASE 6,SERINE/THREONINE-PROTEIN KINASE AYK1,SERINE/THREONINE- COMPND 8 PROTEIN KINASE AURORA-A; COMPND 9 EC: 2.7.11.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PHAT4 KEYWDS PROTEIN-LIGAND COMPLEX, KINASE, PROTEIN-PROTEIN INTERACTION KEYWDS 2 INHIBITOR, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR G.FISCHER,M.ROCABOY,B.BLASZCZYK,T.MOSCHETTI,X.WANG,D.E.SCOTT, AUTHOR 2 A.G.COYNE,C.DAGOSTIN,T.ROONEY,A.BAYLY,J.FENG,A.ASTEIAN,A.ALCAIDE- AUTHOR 3 LOPEZ,S.STOCKWELL,J.SKIDMORE,A.R.VENKITARAMAN,C.ABELL,T.L.BLUNDELL, AUTHOR 4 M.HYVONEN REVDAT 1 10-JAN-24 8C1M 0 JRNL AUTH S.STOCKWELL,D.SCOTT,G.FISCHER,E.GUARINO ALMEIDA,T.ROONEY, JRNL AUTH 2 J.FENG,T.MOSCHETTI,C.DAGOSTIN,A.ALCAIDE-LOPEZ,M.ROCABOY, JRNL AUTH 3 R.SRINIVASAN,A.ASTEIAN,E.ALZA,B.BLASZCZYK,X.WANG,M.ROSSMANN, JRNL AUTH 4 T.PERRIOR,T.L.BLUNDELL,D.R.SPRING,G.MCKENZIE,C.ABELL, JRNL AUTH 5 J.SKIDMORE,A.VENKITARAMAN,M.HYVONEN JRNL TITL SELECTIVE INHIBITORS OF THE AURORA A-TPX2 PROTEIN-PROTEIN JRNL TITL 2 INTERACTION EXHIBIT IN VIVO EFFICACY AS TARGETED JRNL TITL 3 ANTI-MITOTIC AGENT JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 11861 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.252 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 584 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.88 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2993 REMARK 3 BIN FREE R VALUE : 0.5591 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 25 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2161 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 82.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -17.08870 REMARK 3 B22 (A**2) : -17.08870 REMARK 3 B33 (A**2) : 34.17750 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.460 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.629 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.328 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.613 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.330 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.880 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2266 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3073 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 798 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 378 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2266 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 278 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1577 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.87 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.55 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.50 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8C1M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1292127632. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9200 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11913 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.840 REMARK 200 RESOLUTION RANGE LOW (A) : 53.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 12.40 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.91 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.82800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% DMSO, 0.2M MGSO4, 0.05 M HEPES 7.4: REMARK 280 SOAKING: 0.2M MGSO4, 0.05M HEPES 7.4, 30% GLYCEROL, 10% DMSO, 5 REMARK 280 MM COMPOUND, PH 6.5, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.50000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 41.41000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 41.41000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 34.75000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 41.41000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 41.41000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 104.25000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 41.41000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.41000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 34.75000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 41.41000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.41000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 104.25000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.50000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 119 REMARK 465 GLY A 120 REMARK 465 SER A 121 REMARK 465 MET A 122 REMARK 465 GLY A 123 REMARK 465 SER A 124 REMARK 465 LYS A 125 REMARK 465 ARG A 126 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 TPO A 288 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 155 -41.54 162.39 REMARK 500 HIS A 187 34.41 -99.20 REMARK 500 ASP A 202 -153.16 -120.50 REMARK 500 ASP A 256 39.42 -145.76 REMARK 500 ASP A 274 68.72 64.71 REMARK 500 PHE A 275 30.82 -82.42 REMARK 500 SER A 284 -4.80 -142.16 REMARK 500 THR A 287 -89.53 -92.37 REMARK 500 CYS A 290 52.20 -144.61 REMARK 500 ASP A 294 -36.23 -36.94 REMARK 500 ASP A 307 -156.06 -135.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 401 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 274 OD2 REMARK 620 2 ADP A 404 O2B 86.9 REMARK 620 3 ADP A 404 O2A 77.3 80.4 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 403 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 274 OD1 REMARK 620 2 ADP A 404 O3B 71.9 REMARK 620 N 1 DBREF 8C1M A 125 391 UNP O14965 AURKA_HUMAN 125 391 SEQADV 8C1M GLN A 119 UNP O14965 EXPRESSION TAG SEQADV 8C1M GLY A 120 UNP O14965 EXPRESSION TAG SEQADV 8C1M SER A 121 UNP O14965 EXPRESSION TAG SEQADV 8C1M MET A 122 UNP O14965 EXPRESSION TAG SEQADV 8C1M GLY A 123 UNP O14965 EXPRESSION TAG SEQADV 8C1M SER A 124 UNP O14965 EXPRESSION TAG SEQRES 1 A 273 GLN GLY SER MET GLY SER LYS ARG GLN TRP ALA LEU GLU SEQRES 2 A 273 ASP PHE GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE SEQRES 3 A 273 GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE SEQRES 4 A 273 ILE LEU ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU SEQRES 5 A 273 LYS ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU SEQRES 6 A 273 ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU SEQRES 7 A 273 TYR GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE SEQRES 8 A 273 LEU GLU TYR ALA PRO LEU GLY THR VAL TYR ARG GLU LEU SEQRES 9 A 273 GLN LYS LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR SEQRES 10 A 273 TYR ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SEQRES 11 A 273 SER LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN SEQRES 12 A 273 LEU LEU LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP SEQRES 13 A 273 PHE GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG THR SEQRES 14 A 273 TPO LEU CYS GLY THR LEU ASP TYR LEU PRO PRO GLU MET SEQRES 15 A 273 ILE GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SEQRES 16 A 273 SER LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS SEQRES 17 A 273 PRO PRO PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS SEQRES 18 A 273 ARG ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL SEQRES 19 A 273 THR GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS SEQRES 20 A 273 HIS ASN PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU SEQRES 21 A 273 GLU HIS PRO TRP ILE THR ALA ASN SER SER LYS PRO SER MODRES 8C1M TPO A 288 THR MODIFIED RESIDUE HET TPO A 288 11 HET MG A 401 1 HET T4X A 402 21 HET MG A 403 1 HET ADP A 404 27 HETNAM TPO PHOSPHOTHREONINE HETNAM MG MAGNESIUM ION HETNAM T4X 3-OXIDANYL-5-[4-(TRIFLUOROMETHYLOXY)PHENYL]BENZOIC ACID HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 MG 2(MG 2+) FORMUL 3 T4X C14 H9 F3 O4 FORMUL 5 ADP C10 H15 N5 O10 P2 HELIX 1 AA1 ALA A 129 GLU A 131 5 3 HELIX 2 AA2 LYS A 166 GLY A 173 1 8 HELIX 3 AA3 VAL A 174 HIS A 187 1 14 HELIX 4 AA4 THR A 217 LEU A 225 1 9 HELIX 5 AA5 ASP A 229 LYS A 250 1 22 HELIX 6 AA6 LYS A 258 GLU A 260 5 3 HELIX 7 AA7 ASP A 274 SER A 278 5 5 HELIX 8 AA8 PRO A 297 GLU A 302 1 6 HELIX 9 AA9 GLU A 308 GLY A 325 1 18 HELIX 10 AB1 THR A 333 ARG A 343 1 11 HELIX 11 AB2 THR A 353 LEU A 364 1 12 HELIX 12 AB3 ASN A 367 ARG A 371 5 5 HELIX 13 AB4 MET A 373 GLU A 379 1 7 HELIX 14 AB5 HIS A 380 SER A 387 1 8 SHEET 1 AA1 5 PHE A 133 GLY A 142 0 SHEET 2 AA1 5 GLY A 145 GLU A 152 -1 O LEU A 149 N GLY A 136 SHEET 3 AA1 5 ILE A 158 PHE A 165 -1 O LEU A 161 N TYR A 148 SHEET 4 AA1 5 ARG A 205 GLU A 211 -1 O LEU A 210 N ALA A 160 SHEET 5 AA1 5 LEU A 196 HIS A 201 -1 N PHE A 200 O TYR A 207 SHEET 1 AA2 2 VAL A 252 ILE A 253 0 SHEET 2 AA2 2 VAL A 279 HIS A 280 -1 O VAL A 279 N ILE A 253 SHEET 1 AA3 2 LEU A 262 LEU A 264 0 SHEET 2 AA3 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 LINK C THR A 287 N TPO A 288 1555 1555 1.33 LINK C TPO A 288 N LEU A 289 1555 1555 1.34 LINK OD2 ASP A 274 MG MG A 401 1555 1555 2.20 LINK OD1 ASP A 274 MG MG A 403 1555 1555 2.75 LINK MG MG A 401 O2B ADP A 404 1555 1555 2.52 LINK MG MG A 401 O2A ADP A 404 1555 1555 2.33 LINK MG MG A 403 O3B ADP A 404 1555 1555 2.14 CISPEP 1 ALA A 281 PRO A 282 0 -0.18 CRYST1 82.820 82.820 139.000 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012074 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012074 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007194 0.00000